#1 Clinical Trials Search in Europe

Ciprofloxacin

Ciprofloxacin, a widely used antibiotic, has been the subject of numerous clinical trials to evaluate its effectiveness in treating various medical conditions. This article explores the use of ciprofloxacin in different formulations and dosages across several clinical studies. From ear infections to urinary tract issues, researchers have been investigating how this versatile antibiotic can be optimally used to improve patient outcomes.

Table of Contents

What is Ciprofloxacin?

Ciprofloxacin is a powerful antibiotic that belongs to a class of drugs called fluoroquinolones. It works by stopping the growth of bacteria that cause infections. Ciprofloxacin is known by several brand names, including Cipro, Cipro XR, and Otiprio, depending on its formulation and use[1][2][3].

Uses of Ciprofloxacin

Ciprofloxacin is used to treat a variety of bacterial infections, including:

  • Urinary Tract Infections (UTIs): Ciprofloxacin is effective in treating both uncomplicated and complicated UTIs, including those caused by Pseudomonas aeruginosa, a type of bacteria that can be difficult to treat[1][4].
  • Ear Infections: Ciprofloxacin is used in the treatment of otitis externa (outer ear infection) and otitis media (middle ear infection), especially in children with tympanostomy tubes (small tubes inserted into the eardrum to drain fluid)[3][5].
  • Dysentery: Ciprofloxacin is used to treat severe diarrheal infections, including those caused by Shigella bacteria[6].
  • Prostate Infections: It can be used as a preventive measure (prophylaxis) before prostate biopsies to reduce the risk of infection[7].

Forms and Administration

Ciprofloxacin comes in several forms, each designed for specific uses:

  • Oral tablets: These include immediate-release (IR) and extended-release (XR) formulations. The XR version is often taken once daily, while the IR version may be taken twice daily[4].
  • Ear drops: For ear infections, ciprofloxacin may be combined with other medications like hydrocortisone (e.g., Cipro HC) and administered as ear drops[5].
  • Otic suspension: A special formulation called Otiprio is used for ear infections in children with tympanostomy tubes. It’s administered as a single dose during surgery and forms a gel in the ear, slowly releasing the medication over time[3].

Effectiveness

Ciprofloxacin has been shown to be effective in treating various infections:

  • For UTIs, both extended-release and immediate-release formulations have demonstrated high success rates in clinical trials[1][4].
  • In ear infections, ciprofloxacin-containing ear drops have been effective in reducing pain, swelling, and discharge (otorrhea)[5].
  • For dysentery, ciprofloxacin is being compared to other antibiotics like azithromycin to determine the most effective treatment[6].

Side Effects

While ciprofloxacin is generally well-tolerated, it can cause side effects. Common side effects may include:

  • Nausea
  • Diarrhea
  • Headache
  • Dizziness

More serious side effects, though rare, can occur. These may include tendon problems, nerve damage, and changes in blood sugar levels. It’s important to discuss any side effects with your healthcare provider[4].

Special Considerations

When using ciprofloxacin, keep in mind:

  • The duration of treatment can vary depending on the type and severity of the infection. For example, UTIs may be treated for 7-14 days[4].
  • For ear infections in children, single-dose formulations like Otiprio can eliminate the need for parents to administer multiple doses at home[3].
  • Ciprofloxacin can interact with other medications, so always inform your healthcare provider about all medications you’re taking.
  • In some cases, ciprofloxacin may be combined with other medications for enhanced effectiveness, such as with hydrocortisone for ear infections[5].

Always follow your healthcare provider’s instructions when taking ciprofloxacin, and complete the full course of treatment even if you start feeling better before it’s finished.

Aspect Details
Conditions Studied Otitis media, otitis externa, complicated urinary tract infections, prostate biopsy prophylaxis
Ciprofloxacin Formulations Extended-release tablets, immediate-release tablets, ear drops, otic suspensions
Dosages Ranging from 500 mg twice daily to 1000 mg once daily for oral formulations; varied for otic formulations
Duration of Treatment Varies by condition: 3-14 days for most studies
Primary Outcomes Symptom relief, bacteriological response, clinical cure rates
Secondary Outcomes Time to symptom improvement, adverse events, quality of life measures
Special Populations Children with ear infections, adults with complicated UTIs, patients undergoing prostate biopsies
Comparison Treatments Different ciprofloxacin formulations, other antibiotics, placebo in some cases

FAQ

  • What conditions are being studied with ciprofloxacin in these clinical trials? The clinical trials are studying ciprofloxacin's effectiveness in treating various conditions, including otitis media (middle ear infection), otitis externa (outer ear infection), complicated urinary tract infections, and as a preventive measure for prostate biopsies.
  • What are some of the different formulations of ciprofloxacin being tested? The trials are testing different formulations of ciprofloxacin, including extended-release tablets (Cipro XR), immediate-release tablets, ear drops (often combined with other medications like hydrocortisone), and otic suspensions for ear infections.
  • How is ciprofloxacin being compared to other treatments in these studies? In some studies, ciprofloxacin is being compared to other antibiotics or different dosing regimens of the same drug. For example, one study compares Cipro XR (extended-release) to Cipro IR (immediate-release) for urinary tract infections.
  • What are the main outcomes being measured in these ciprofloxacin trials? The main outcomes being measured include the effectiveness in treating the targeted condition (e.g., resolving infections, reducing symptoms), the time to symptom improvement, bacteriological response, and the identification of potential side effects or adverse events.
  • Are there any special populations being studied in these ciprofloxacin trials? Yes, some trials focus on specific populations. For instance, one study looks at the use of ciprofloxacin in children with otitis media, while another examines its use in adults undergoing prostate biopsies. There are also studies specifically for complicated urinary tract infections in adults.

Ongoing Clinical Trials on Ciprofloxacin

  • Study on Reducing Infections After Bladder Removal Surgery Using Pivmecillinam Hydrochloride and Other Antibiotics for Patients Undergoing Ureteral Stent Removal

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on Shortened Antibiotic Treatment for Gram-negative Bacteremia in Hospitalized Adults Using Pivmecillinam Hydrochloride and Drug Combination

    Recruiting

    3 1 1 1
    Investigated drugs:
    Denmark

  • Study on Upadacitinib for Children with Moderate to Severe Crohn’s Disease

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Bulgaria France Greece Italy Poland +1

  • Study Comparing Dalbavancin to Standard Antibiotics for Patients with Staphylococcus aureus Bloodstream Infections

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study Comparing Ciprofloxacin, Colistimethate Sodium, and Ceftazidime for Treating Early Airway Infection in Adults with Bronchiectasis

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on the Effectiveness of Moxifloxacin and Drug Combination for Treating Bone Implant Infections in Patients with Long Bone Fractures

    Recruiting

    3 1 1 1
    Investigated drugs:
    Spain

  • Study on the Effectiveness and Safety of Vedolizumab for Children with Chronic Pouchitis Using a Drug Combination

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Croatia Czechia Denmark Greece Italy +2

  • Study on the Effectiveness and Safety of 7 vs. 14 Days of Antibiotic Treatment with Meropenem for Patients with Pseudomonas Aeruginosa Blood Infection

    Recruiting

    3 1 1 1
    Investigated drugs:
    Spain

  • Study on Early Oral Antibiotic Treatment for Vertebral Osteomyelitis Using Cefuroxime, Dicloxacillin, and Ceftriaxone for Adult Patients

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on the Safety and Effectiveness of SpectraCure P18 System and Verteporfin for Treating Recurrent Prostate Cancer

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Sweden

Glossary

  • Otitis Media: An infection or inflammation of the middle ear, often seen in children. It can cause pain, fever, and temporary hearing problems.
  • Otitis Externa: An infection of the outer ear canal, also known as swimmer's ear. It can cause pain, itching, and discharge from the ear.
  • Tympanostomy Tube: A small tube inserted into the eardrum to allow air into the middle ear and prevent fluid buildup. It's often used to treat recurrent ear infections.
  • Otorrhea: Discharge from the ear, which can be a sign of infection or other ear problems.
  • Urinary Tract Infection (UTI): An infection in any part of the urinary system, including the kidneys, bladder, and urethra. It often causes pain or burning during urination and frequent urges to urinate.
  • Ciprofloxacin: A broad-spectrum antibiotic belonging to the fluoroquinolone class. It's used to treat various bacterial infections.
  • Extended-Release (XR): A medication formulation designed to release the active ingredient slowly over time, allowing for less frequent dosing.
  • Immediate-Release (IR): A medication formulation that releases the active ingredient quickly after ingestion.
  • Otic: Relating to the ear. Otic medications are designed for use in or around the ear.
  • Bacteriological Response: The effectiveness of a treatment in eliminating bacteria causing an infection, often measured by laboratory tests.

References

  1. https://clinicaltrials.gov/study/NCT00676533
  2. https://clinicaltrials.gov/study/NCT00481689
  3. https://clinicaltrials.gov/study/NCT03347461
  4. https://clinicaltrials.gov/study/NCT00668122
  5. https://clinicaltrials.gov/study/NCT00980876
  6. https://clinicaltrials.gov/study/NCT03854929
  7. https://clinicaltrials.gov/study/NCT00294749